Mittal D, Young A, Stannard K, Yong M, Teng MW, Allard B, Stagg J, Smyth MJ. Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor. Cancer Res. 2014 Jul 1. [Epub ahead of print]
Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, Jones L, Crough T, Dasari V, Klein K, Smalley A, Alexander H, Walker DG, Khanna R. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014 Jul 1;74(13):3466-76.
Liu YC, Chen Z, Neller MA, Miles JJ, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism. J Biol Chem. 2014 Jun 13;289(24):16688-16698.
West AC, Smyth MJ, Johnstone RW. The anticancer effects of HDAC inhibitors require the immune system. Oncoimmunology. 2014 Jan 1;3(1):e27414.


From the CIVD Director
Vaccine research requires a multi-disciplinary strategy which involves expertise in basic and applied immunology, pathogenesis, molecular and structural biology with preclinical and clinical trials methodology.QIMR Berghofer Medical Research Institute encompasses this varied expertise within a single institution and the CIVD harnesses this to advance the science of vaccine development.
Professor Rajiv Khanna
T +61 7 3362 0385
E Rajiv.Khanna@qimrberghofer.edu.au